Estimating the burden of disease in an English region

被引:25
作者
Bowie, C
Beck, S
Bevan, G
Raftery, J
Silverton, F
Stevens, A
机构
[1] WESSEX INST HLTH RES & DEV,WINCHESTER SO22 5DH,HANTS,ENGLAND
[2] UNIV BRISTOL,DEPT SOCIAL MED,BRISTOL BS8 2PR,AVON,ENGLAND
[3] UNIV BIRMINGHAM,SCH PUBL POLICY,HLTH SERV MANAGEMENT CTR,BIRMINGHAM B15 2RT,W MIDLANDS,ENGLAND
来源
JOURNAL OF PUBLIC HEALTH MEDICINE | 1997年 / 19卷 / 01期
关键词
health economics; DALY; QALY; programme budgeting;
D O I
10.1093/oxfordjournals.pubmed.a024595
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Health Authorities seeking to make appropriate investments in health care require information about the nature of the burden of disease in their populations. The World Bank instrument called DALY - Disability Adjusted Life Year - has been used in the South and West Region to measure this burden. Method The burden of disease caused by a selection of diseases has been calculated using DALYs, which combine premature mortality and disability. An estimate of the total burden has been estimated by ICD chapter. Results Premature mortality accounts for 52 per cent of the burden of disease and disability 48 per cent. Mental illness, for which its DALY value is largely derived from disability not premature mortality, contributes the third largest component of the total burden, after heart disease and cancer. Discussion DALYs can be calculated using UK data, and, with an appreciation of the theoretical issues which surround the calculations, can be used to describe the burden of disease in a population. Although designed to assist investment decisions in developing countries, the DALY is likely to be valuable in established market economies.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 15 条
[1]  
BUNKER JP, 1995, J ROY COLL PHYS LOND, V29, P105
[2]   MARGINAL ANALYSIS IN PRACTICE - AN ALTERNATIVE TO NEEDS ASSESSMENT FOR CONTRACTING HEALTH-CARE [J].
COHEN, D .
BRITISH MEDICAL JOURNAL, 1994, 309 (6957) :781-784
[3]   ECONOMICS, PUBLIC-HEALTH AND HEALTH-CARE PURCHASING - REINVENTING THE WHEEL [J].
DONALDSON, C .
HEALTH POLICY, 1995, 33 (02) :79-90
[4]  
Gold MR., 1996, COST EFFECTIVENESS H
[5]  
HOLLAND WW, 1991, EUROPEAN COMMUNITY A, V1
[6]  
Mooney G, 1994, KEY ISSUES HLTH EC
[7]  
MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P447
[8]  
MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495
[9]  
MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429
[10]  
MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P481